Gilead Sciences

Return To Sender stamp on an envelope
Biotech

Gilead hands back one Arcus cancer candidate from $725M deal

The news confirms Gilead's retreat from an asset Arcus deprioritized earlier this year.
Nick Paul Taylor Aug 7, 2025 6:35am
Uninhabited island full of trees

Galapagos builds island of cell therapies amid pipeline pruning

Jul 24, 2025 10:59am
Realistic white price tags collection Special offer or shopping discount label

China biotechs ‘reshaping’ US biopharma: Jefferies report

Jul 14, 2025 2:30pm
Whale swimming in ocean seen from above

Merck wades deeper into HIV PrEP waters with pair of trials

Jul 14, 2025 1:12pm
Gilead

Gilead blames low infection rates for ending 2 RSV trials

Jun 27, 2025 4:09am
positive negative up down good bad mixed

Kymera suffers Sanofi setback but secures $750M Gilead deal

Jun 25, 2025 9:31am